Search Results - "Patel, Rajan K."

Renal association clinical practice guideline in post-operative care in the kidney transplant recipient by Baker, Richard J, Mark, Patrick B, Patel, Rajan K, Stevens, Kate K, Palmer, Nicholas

“…These guidelines cover the care of patients from the period following kidney transplantation until the transplant is no longer working or the patient dies…”
Get full text

Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis by Findlay, Mark D., Thomson, Peter C., Fulton, Rachael L., Solbu, Marit D., Jardine, Alan G., Patel, Rajan K., Stevens, Kathryn K., Geddes, Colin C., Dawson, Jesse, Mark, Patrick B.

“…BACKGROUND AND PURPOSE—End-stage renal disease (ESRD) requiring hemodialysis carries up to a 10-fold greater risk of stroke than normal renal function…”
Get full text

Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal by Rankin, Alastair J, Mangion, Kenneth, Lees, Jennifer S, Rutherford, Elaine, Gillis, Keith A, Edy, Elbert, Dymock, Laura, Treibel, Thomas A, Radjenovic, Aleksandra, Patel, Rajan K, Berry, Colin, Roditi, Giles, Mark, Patrick B

“…Mapping of left ventricular (LV) native T1 is a promising non-invasive, non-contrast imaging biomarker. Native myocardial T1 times are prolonged in patients…”
Get full text

Serum Chloride Is an Independent Predictor of Mortality in Hypertensive Patients by McCallum, Linsay, Jeemon, Panniyammakal, Hastie, Claire E, Patel, Rajan K, Williamson, Catherine, Redzuan, Adyani Md, Dawson, Jesse, Sloan, William, Muir, Scott, Morrison, David, McInnes, Gordon T, Freel, Ellen Marie, Walters, Matthew, Dominiczak, Anna F, Sattar, Naveed, Padmanabhan, Sandosh

“…Chloride (Cl) is the major extracellular anion in the body, accompanying sodium (Na), and is primarily derived from dietary sources. Data suggest that…”
Get full text

Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies by Durussel, Jérôme, Haile, Diresibachew W, Mooses, Kerli, Daskalaki, Evangelia, Beattie, Wendy, Mooses, Martin, Mekonen, Wondyefraw, Ongaro, Neford, Anjila, Edwin, Patel, Rajan K, Padmanabhan, Neal, McBride, Martin W, McClure, John D, Pitsiladis, Yannis P

“…Recombinant human erythropoietin (rHuEPO) is frequently abused by athletes as a performance-enhancing drug, despite being prohibited by the World Anti-Doping…”
Get full text

Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men by Durussel, Jérôme, Daskalaki, Evangelia, Anderson, Martin, Chatterji, Tushar, Wondimu, Diresibachew H, Padmanabhan, Neal, Patel, Rajan K, McClure, John D, Pitsiladis, Yannis P

“…Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake (v O(2 max)). This study defined the time course of…”
Get full text

Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease by Gillis, Keith A, McComb, Christie, Patel, Rajan K, Stevens, Kathryn K, Schneider, Markus P, Radjenovic, Aleksandra, Morris, Scott T W, Roditi, Giles H, Delles, Christian, Mark, Patrick B

“…Arterial spin labelling (ASL) MRI measures perfusion without administration of contrast agent. While ASL has been validated in animals and healthy volunteers…”
Get more information

Risk factors and outcome of stroke in renal transplant recipients by Findlay, Mark D., Thomson, Peter C., MacIsaac, Rachael, Jardine, Alan G., Patel, Rajan K., Stevens, Kathryn K., Rutherford, Elaine, Clancy, Marc, Geddes, Colin C., Dawson, Jesse, Mark, Patrick B.

“…Stroke incidence is high in end‐stage renal disease, and risk factors differ between the dialysis and general populations. However, risk factors and outcomes…”
Get full text

Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging by Patel, Rajan K, Oliver, Scott, Mark, Patrick B, Powell, Joanna R, McQuarrie, Emily P, Traynor, James P, Dargie, Henry J, Jardine, Alan G

“…Left ventricular hypertrophy (LVH) is an independent risk factor for premature cardiovascular death in hemodialysis (HD) patients and one of the three forms of…”
Get full text

Renal Transplantation Is Not Associated with Regression of Left Ventricular Hypertrophy: A Magnetic Resonance Study by Patel, Rajan K, Mark, Patrick B, Johnston, Nicola, McGregor, Ellon, Dargie, Henry J, Jardine, Alan G

“…Patients with end-stage renal failure (ESRD) have an increased risk of premature cardiovascular (CV) disease. Left ventricular hypertrophy is an independent…”
Get full text

Association of Left Atrial Volume With Mortality Among ESRD Patients With Left Ventricular Hypertrophy Referred for Kidney Transplantation by Patel, Rajan K., MBChB, Jardine, Alan G.M., BSc, Mark, Patrick B., PhD, Cunningham, Anthony F., BSc, Steedman, Tracey, BSc, Powell, Joanna R., MBChB, McQuarrie, Emily P., MBChB, Stevens, Kathryn K., MBChB, Dargie, Henry J., MD, Jardine, Alan G., MD

“…Background Left ventricular hypertrophy (LVH) is common in patients with end-stage renal disease (ESRD) and an independent risk factor for premature…”
Get full text

Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study by Green, Darren, Vassallo, Diana, Handley, Kelly, Ives, Natalie, Wheatley, Keith, Chrysochou, Constantina, Hegarty, Janet, Wright, Julian, Moss, Jon, Patel, Rajan K, Deighan, Chris, Webster, John, Rowe, Peter, Carr, Sue, Cross, Jenny, O'Driscoll, Jamie, Sharma, Raj, Mark, Patrick, Kalra, Philip A

“…The ASTRAL trial showed no difference in clinical outcomes between medical therapy and revascularization for atherosclerotic renal vascular disease (ARVD)…”
Get full text

Microvolt T-Wave Alternans in End-Stage Renal Disease Patients—Associations with Uremic Cardiomyopathy by Patel, Rajan K, Mark, Patrick B, Halliday, Crawford, Steedman, Tracey, Dargie, Henry J, Cobbe, Stuart M, Jardine, Alan G

“…Premature cardiovascular (CV) events, especially sudden cardiac death, are common in ESRD patients and associated with uremic cardiomyopathy. Identification of…”
Get full text

Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease by McQuarrie, Emily P, Freel, E Marie, Mark, Patrick B, Fraser, Robert, Patel, Rajan K, Dargie, Henry G, Connell, John M C, Jardine, Alan G

“…Blockade of the MR (mineralocorticoid receptor) in CKD (chronic kidney disease) reduces LVMI [LV (left ventricular) mass index] and proteinuria. The MR can be…”
Get more information

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping by Rutherford, Elaine, Talle, Mohammed A, Mangion, Kenneth, Bell, Elizabeth, Rauhalammi, Samuli M, Roditi, Giles, McComb, Christie, Radjenovic, Aleksandra, Welsh, Paul, Woodward, Rosemary, Struthers, Allan D, Jardine, Alan G, Patel, Rajan K, Berry, Colin, Mark, Patrick B

“…Noninvasive quantification of myocardial fibrosis in end-stage renal disease is challenging. Gadolinium contrast agents previously used for cardiac magnetic…”
Get more information

Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway by Stevens, Kathryn K, Denby, Laura, Patel, Rajan K, Mark, Patrick B, Kettlewell, Sarah, Smith, Godfrey L, Clancy, Marc J, Delles, Christian, Jardine, Alan G

“…Hyperphosphataemia is an independent risk factor for accelerated cardiovascular disease in chronic kidney disease (CKD), although the mechanism for this is…”
Get full text

A descriptive analysis of non-human leukocyte antigens present in renal transplant donor-recipient pairs by Sisk, Louis J., Patel, Rajan K., Stevens, Kathryn K.

“…End stage renal disease (ESRD) is the irreversible deterioration of renal function requiring renal replacement therapy by dialysis or transplant. Human…”
Get full text

Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients by Mark, Patrick B, Mangion, Kenneth, Rankin, Alastair J, Rutherford, Elaine, Lang, Ninian N, Petrie, Mark C, Stoumpos, Sokratis, Patel, Rajan K

“…Chronic kidney disease (CKD) is a risk factor for premature cardiovascular disease. As kidney function declines, the presence of left ventricular abnormalities…”
Get full text

Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation by McQuarrie, Emily P., Hillyard, Dianne Z., Stevens, Kathryn K., Jardine, Alan G., Mark, Patrick B., Patel, Rajan K., Sands, William

“…Elevated FGF-23 is a predictor of mortality and is associated with LVH in CKD. It may be a biomarker or a direct toxin. We assessed the relationship between…”
Get full text

Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF by Curtain, James P., Talebi, Atefeh, McIntosh, Alasdair, McConnachie, Alex, O'Donnell, Joanne, Welsh, Paul, Osmanska, Joanna, Lee, Matthew M.Y., Sonecki, Piotr, Akl, Tony, Seo, Joohyun, Gopinathan, Venugopal, Hurwitz, Jed, Thiagarajan, Srikanth, Pettit, Stephen, Kalra, Paul R., Patel, Rajan K., Mark, Patrick B., Lang, Ninian N., McMurray, John J.V., Petrie, Mark C., Gardner, Roy S., Jhund, Pardeep S.

“…Aims We examined the effectiveness of a novel cardiopulmonary management wearable sensor (worn for less than 5 mins) at measuring congestion and correlated the…”
Get full text